-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Initiates Coverage On Amphastar Pharma with Equal-Weight Rating, Announces Price Target of $30

Benzinga·12/09/2025 15:22:20
語音播報
Barclays analyst Glen Santangelo initiates coverage on Amphastar Pharma (NASDAQ:AMPH) with a Equal-Weight rating and announces Price Target of $30.